OSTEOGENESIS IMPERFECTA
Clinical trials for OSTEOGENESIS IMPERFECTA explained in plain language.
Never miss a new study
Get alerted when new OSTEOGENESIS IMPERFECTA trials appear
Sign up with your email to follow new studies for OSTEOGENESIS IMPERFECTA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to strengthen bones in kids with rare brittle bone disease
Disease control OngoingThis phase 3 study tests setrusumab, a monthly IV infusion, in 6 Japanese children with osteogenesis imperfecta (types I, III, or IV), a condition that causes fragile bones and frequent fractures. The main goal is to see if the drug lowers the number of fractures, including spine…
Matched conditions: OSTEOGENESIS IMPERFECTA
Phase: PHASE3 • Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug aims to slash fractures in kids with brittle bones
Disease control OngoingThis study tests a drug called romosozumab against standard bone-strengthening medicines (bisphosphonates) in children and teens with osteogenesis imperfecta, a condition that causes fragile bones and frequent fractures. The goal is to see if romosozumab can reduce the number of …
Matched conditions: OSTEOGENESIS IMPERFECTA
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug aims to slash fractures in brittle bone disease
Disease control OngoingThis study tests a medicine called setrusumab in people with osteogenesis imperfecta (brittle bone disease). The goal is to see if it can lower the number of bone fractures. About 183 participants with types I, III, or IV of the disease who have had recent fractures will receive …
Matched conditions: OSTEOGENESIS IMPERFECTA
Phase: PHASE2, PHASE3 • Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New drug aims to cut fractures in kids with brittle bones
Disease control OngoingThis study tests a new medicine called setrusumab against standard bone-strengthening drugs (bisphosphonates) in children aged 2 to under 7 with osteogenesis imperfecta (brittle bone disease) types I, III, or IV. The goal is to see if setrusumab can lower the number of bone break…
Matched conditions: OSTEOGENESIS IMPERFECTA
Phase: PHASE3 • Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Fetal stem cells aim to mend broken bones in infants
Disease control OngoingThis early-phase trial tests whether fetal stem cells given before or after birth can safely help infants with severe osteogenesis imperfecta, a genetic condition causing fragile bones and frequent fractures. Up to 18 children will receive multiple doses of the cells. The main go…
Matched conditions: OSTEOGENESIS IMPERFECTA
Phase: PHASE1, PHASE2 • Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Jun 26, 2026 15:45 UTC
-
Invisalign offers hope for safer smiles in osteogenesis imperfecta
Symptom relief OngoingThis study tests whether Invisalign clear aligners can safely straighten teeth in people with Osteogenesis Imperfecta (OI), a condition that makes bones brittle and dental work risky. About 57 participants aged 12 to 40 with mild to moderate teeth misalignment will receive treatm…
Matched conditions: OSTEOGENESIS IMPERFECTA
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Breathing problems in brittle bone disease: new study seeks answers
Knowledge-focused OngoingThis study examines lung and heart function in 18 adults with osteogenesis imperfecta (OI), also known as brittle bone disease. Researchers want to understand why breathing problems are the leading cause of death in OI. Participants will undergo lung function tests and chest imag…
Matched conditions: OSTEOGENESIS IMPERFECTA
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Brittle bone disease linked to severe teeth misalignment – new study investigates
Knowledge-focused OngoingThis study looks at teeth misalignment and neck defects in people with moderate to severe osteogenesis imperfecta (OI), a rare condition that causes bones to break easily. Researchers will use scans of the teeth, jaw, and neck to measure these problems in 75 participants aged 10 …
Matched conditions: OSTEOGENESIS IMPERFECTA
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Pee power: urine test may replace needles for brittle bone diagnosis
Knowledge-focused OngoingThis study is testing whether a urine test can help identify different genetic types of osteogenesis imperfecta (OI), a rare condition that causes bones to break easily. Researchers will measure certain collagen peptides in the urine of 25 people with OI. If successful, this coul…
Matched conditions: OSTEOGENESIS IMPERFECTA
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC